The outcome validate conclusions drawn by Bagli et al. [one], who conducted a research that bundled ten patients diagnosed with CRAO who obtained HBOT. In combination with getting 20 periods of HBOT, oral acetazolamide and topical beta-blockers were administered to the patients in the earliest achie